Innovent Biologics, Inc. (HKG:1801)

Innovent Biologics Statistics

Total Valuation

HKG:1801 has a market cap or net worth of HKD 165.11 billion. The enterprise value is 158.36 billion.

Market Cap	165.11B
Enterprise Value	158.36B

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1801 has 1.71 billion shares outstanding. The number of shares has increased by 3.74% in one year.

Current Share Class	1.71B
Shares Outstanding	1.71B
Shares Change (YoY)	+3.74%
Shares Change (QoQ)	+3.84%
Owned by Insiders (%)	6.48%
Owned by Institutions (%)	42.04%
Float	1.59B

Valuation Ratios

The trailing PE ratio is 130.40 and the forward PE ratio is 101.89.

PE Ratio	130.40
Forward PE	101.89
PS Ratio	13.19
PB Ratio	10.45
P/TBV Ratio	11.56
P/FCF Ratio	104.08
P/OCF Ratio	82.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 114.31, with an EV/FCF ratio of 99.82.

EV / Earnings	127.63
EV / Sales	12.65
EV / EBITDA	114.31
EV / EBIT	167.12
EV / FCF	99.82

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.23.

Current Ratio	2.61
Quick Ratio	2.25
Debt / Equity	0.23
Debt / EBITDA	2.54
Debt / FCF	2.33
Interest Coverage	10.22

Financial Efficiency

Return on equity (ROE) is 8.43% and return on invested capital (ROIC) is 3.46%.

Return on Equity (ROE)	8.43%
Return on Assets (ROA)	2.65%
Return on Invested Capital (ROIC)	3.46%
Return on Capital Employed (ROCE)	5.00%
Revenue Per Employee	2.02M
Profits Per Employee	200,446
Employee Count	5,659
Asset Turnover	0.52
Inventory Turnover	2.94

Taxes

In the past 12 months, HKG:1801 has paid 86.32 million in taxes.

Income Tax	86.32M
Effective Tax Rate	6.50%

Stock Price Statistics

The stock price has increased by +106.87% in the last 52 weeks. The beta is 0.21, so HKG:1801's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+106.87%
50-Day Moving Average	96.20
200-Day Moving Average	62.64
Relative Strength Index (RSI)	50.89
Average Volume (20 Days)	18,728,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1801 had revenue of HKD 12.52 billion and earned 1.24 billion in profits. Earnings per share was 0.74.

Revenue	12.52B
Gross Profit	9.59B
Operating Income	1.02B
Pretax Income	1.33B
Net Income	1.24B
EBITDA	1.43B
EBIT	1.02B
Earnings Per Share (EPS)	0.74

Balance Sheet

The company has 10.45 billion in cash and 3.70 billion in debt, giving a net cash position of 6.75 billion or 3.94 per share.

Cash & Cash Equivalents	10.45B
Total Debt	3.70B
Net Cash	6.75B
Net Cash Per Share	3.94
Equity (Book Value)	15.80B
Book Value Per Share	9.56
Working Capital	8.85B

Cash Flow

In the last 12 months, operating cash flow was 1.99 billion and capital expenditures -404.04 million, giving a free cash flow of 1.59 billion.

Operating Cash Flow	1.99B
Capital Expenditures	-404.04M
Free Cash Flow	1.59B
FCF Per Share	0.93

Margins

Gross margin is 76.62%, with operating and profit margins of 8.14% and 9.91%.

Gross Margin	76.62%
Operating Margin	8.14%
Pretax Margin	10.60%
Profit Margin	9.91%
EBITDA Margin	11.40%
EBIT Margin	8.14%
FCF Margin	12.67%

Dividends & Yields

HKG:1801 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.74%
Shareholder Yield	n/a
Earnings Yield	0.75%
FCF Yield	0.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1801 has an Altman Z-Score of 4.57 and a Piotroski F-Score of 7.

Altman Z-Score	4.57
Piotroski F-Score	7